Research map: The Relationship Between (Endo)cannabinoids, the Microbiome and Melanoma

Back to the article

Papers in this map

  1. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors · Bertrand Routy · 2017 · 5713 citations · Cited by this paper
  2. Using a N ano BRET ‐Based Ligand‐Binding Assay at the β 2 ‐Adrenoceptor for Undergraduate Pharmacology Education · 2026 · Related
  3. Nivolumab in Previously Untreated Melanoma without BRAF Mutation · Caroline Robert · 2014 · 5444 citations · Cited by this paper
  4. Magnitude, Preventability, and Determinants of Adverse Drug Reactions Among Hospitalized Obstetric Patients in Ethiopia: A Prospective Observational Study · 2026 · Related
  5. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients · Vancheswaran Gopalakrishnan · 2017 · 4864 citations · Cited by this paper
  6. Potent and Sustained Lowering of Serum Uric Acid by YJH ‐012‐D, a G al NA c‐Conjugated si RNA Targeting Xanthine Dehydrogenase · 2026 · Related
  7. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity · Amandine Everard · 2013 · 4551 citations · Cited by this paper
  8. A Prospective Study of Marsh PK ‐ PD Model and Schnider PK ‐ PD Model During Anesthesia Induction for Obese Patients Undergoing Elective Heart Surgery · 2026 · Related
  9. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy · Ayelet Sivan · 2015 · 3922 citations · Cited by this paper
  10. Reported Characteristics of Anaphylaxis Associated With Glatiramer Acetate: A Pharmacovigilance Analysis of the FDA and Canadian Databases · 2026 · Related
  11. Introduction to the human gut microbiota · Elizabeth Thursby · 2017 · 3640 citations · Cited by this paper
  12. Deciphering the Functional Mechanisms of eIF3f in Tumors and Exploring Targeted Therapies · 2026 · Related
  13. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota · Marie Vétizou · 2015 · 3518 citations · Cited by this paper
  14. A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Highly Selective NaV1.8 Inhibitor JKN2306 in Healthy Chinese Subjects · 2026 · Related
  15. The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients · Vyara Z. Matson · 2018 · 3129 citations · Cited by this paper
  16. Student and Graduate Perceptions of Their Development of the Core Attitudes From the British Pharmacological Society's Undergraduate Pharmacology Curriculum · 2026 · Related
  17. Determination and characterization of a cannabinoid receptor in rat brain. · William A. Devane · 1988 · 2445 citations · Cited by this paper
  18. Evaluating the Educational Value of Artificial Intelligence in Pharmacotherapy Education · 2026 · Related
  19. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide · Peter M. Zygmunt · 1999 · 2157 citations · Cited by this paper
  20. Impact of FCGR2A and FCGR3A Gene Variants on the Response to Rituximab in Patients With Glomerular Diseases · 2026 · Related
  21. Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma · Hussein A. Tawbi · 2022 · 1891 citations · Cited by this paper
  22. Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients · Diwakar Davar · 2021 · 1752 citations · Cited by this paper
  23. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 · Roger G. Pertwee · 2010 · 1607 citations · Cited by this paper
  24. Melanoma · Dirk Schadendorf · 2018 · 1523 citations · Cited by this paper
  25. Control of pain initiation by endogenous cannabinoids · Antonio Calignano · 1998 · 1061 citations · Cited by this paper
  26. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response · Christine N. Spencer · 2021 · 963 citations · Cited by this paper
  27. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors · Christel Rousseaux · 2006 · 793 citations · Cited by this paper
  28. The endocannabinoid system links gut microbiota to adipogenesis · Giulio G. Muccioli · 2010 · 690 citations · Cited by this paper
  29. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer · Lisa Derosa · 2022 · 689 citations · Cited by this paper
  30. Modulation of transmitter release via presynaptic cannabinoid receptors · Eberhard Schlicker · 2001 · 672 citations · Cited by this paper
  31. Anandamide and vanilloid TRPV1 receptors · Ruth A. Ross · 2003 · 609 citations · Cited by this paper
  32. Pharmacological Actions of Cannabinoids · Roger G. Pertwee · 2005 · 604 citations · Cited by this paper
  33. CB 2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids · Mohab M. Ibrahim · 2005 · 518 citations · Cited by this paper
  34. CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS · Ken Mackie · 2005 · 510 citations · Cited by this paper
  35. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies · Yuting Lu · 2022 · 499 citations · Cited by this paper
  36. An update on PPAR activation by cannabinoids · Saoirse Elizabeth O’Sullivan · 2016 · 474 citations · Cited by this paper
  37. Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134 · Michael B. Atkins · 2022 · 474 citations · Cited by this paper
  38. Endocannabinoids · Raphael Mechoulam · 1998 · 432 citations · Cited by this paper
  39. Antianxiety effect of cannabidiol in the elevated plus-maze · Francisco Silveira Guimarães · 1990 · 388 citations · Cited by this paper

Source: OpenAlex (CC0)